It hasn't been a great year for Iovance Biotherapeutics (NASDAQ: IOVA), an innovative mid-cap biotech company. Let's look ...

Stocks are at risk heading into 2025, and historically high valuations mean that even slight disappointments could spark a ...

The Dow Jones Industrial Average was off 154.10 points, or nearly 0.4% to end around 44,247.83. The blue-chip index fell for ...

Discover investment decision criteria inspired by Warren Buffett's famous quote. Enbridge and Main Street Capital fit this ...

A survey showed an uptick in people preferring ChatGPT vs Google, and where it's winning over users, from learning a new ...

Shares have advanced in Asia after Wall Street resumed its upward climb as an update on inflation appeared to clear the way ...

The Indian stock market opened marginally up on Thursday ahead of the consumer price index (CPI) data. In the early trade, ...

One of the many curiosities of 2024 has been how global stocks have surged so strongly even as central banks have drained ...

Despite the sharp drop in share price since February 2024, BESIY's fundamentals are still intact. Explore more details here.

Windows 10 gains market share while Windows 11 adoption slows—despite Microsoft's aggressive promotion and the looming end of ...

Foreign institutional investors (FIIs) sold equities worth Rs 1,012.24 crore on December 11, while domestic institutional ...